Apply on Employer Site

Kymera Therapeutics · 16 hours ago

Biostatistics Intern

Greater Boston

Internship

Onsite

Intern

$33/hr - $37/hr

Kymera Therapeutics is a clinical-stage biotechnology company pioneering targeted protein degradation to develop innovative medicines. This internship offers hands-on experience in the pharmaceutical industry, where the intern will assist in statistical analysis of clinical trial data and contribute to ongoing projects in support of clinical development programs.

BiotechnologyHealth CareMedicalTherapeutics

Growth Opportunities

H1B Sponsor Likely

Responsibilities

Assist in statistical analysis of clinical trial data under the guidance of a senior biostatistician

Support development of statistical analysis plans, programming specifications, and summary tables/figures/listings (TFLs)

Perform exploratory data analysis and visualization using statistical software (e.g., R or SAS)

Review and contribute to clinical documents, including protocols and study reports

Conduct literature reviews and/or methodological research on statistical topics relevant to clinical trials or translational studies

Present project findings to the Biometrics team at the end of the internship

Qualification

PhD in BiostatisticsStatistical methodsSAS programmingR programmingStatistical analysisResearch experienceProblem-solvingCommunication skillsTeamwork skillsTime management

Required

Currently enrolled in a PhD program in Biostatistics, Statistics, or a related quantitative discipline

Solid understanding of statistical methods commonly used in clinical trials and biomedical research

Proficiency in statistical programming using SAS, Python, and/or R

Strong problem-solving, communication, and teamwork skills

Ability to manage time effectively and work independently on assigned tasks

Ability to be onsite in Watertown, Ma for 10 weeks in Summer 2026 (start/end dates are flexible)

Preferred

Research experience in any of the following areas is a plus: Handling of missing data in clinical trials, AI/ML modeling techniques, Complex simulations in a clinical or research setting

Company

Kymera Therapeutics

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Founded in 2017

Cambridge, Massachusetts, USA

51-200 employees

http://www.kymeratx.com/

H1B Sponsorship

Kymera Therapeutics has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)

Distribution of Different Job Fields Receiving Sponsorship

Represents job field similar to this job

Trends of Total Sponsorships

2025 (5)

2024 (2)

2023 (4)

2022 (3)

2021 (3)

Funding

Current Stage

Public Company

Total Funding

$1.96B

Key Investors

Biotechnology Value FundAtlas Venture

2025-12-10Post Ipo Equity· $602M

2025-06-26Post Ipo Equity· $250.8M

2024-08-19Post Ipo Equity· $225M

Leadership Team

Nello Mainolfi

Founder, President and Chief Executive Officer

Jeremy Chadwick

Chief Operating Officer

Recent News

Yahoo Finance

Kymera Therapeutics, Inc. (KYMR) Up 28% in 3M, Analysts See Further Upside

2026-01-16

GlobeNewswire

Kymera Therapeutics Outlines Key 2026 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

2026-01-14

Labiotech UG

The biggest biotech funding rounds in December 2025

2026-01-11

Company data provided by crunchbase